You are here


30 May 2013
Headed by EMBL in Germany, the consortium “SyStemAge” seeks to identify the molecular mechanisms behind aging and the consequences of this process, and also to propose biomarkers to combat age-related diseases. The consortium involves clinical researchers, biologists specialized in two types of blood cancer, systems biologists, and biotech managers. Read the full press release on IRB Barcelona ...